The 5 Stages of Parkinson's Disease: A Guide to the Hoehn and Yahr Scale

Key takeaways

  • Parkinson's Disease (PD) is commonly staged 1 to 5 using the Hoehn and Yahr scale, which runs from mild, one-sided symptoms to advanced disease needing substantial help (Hoehn & Yahr, Neurology, 1967).
  • The stages describe where someone is, not how fast they'll progress — the scale carries no fixed timeline, and people can stay in a stage for years (Parkinson's Foundation, Understanding Parkinson's).
  • Progression is highly individual: not everyone reaches the later stages, and symptoms and their severity vary from one person to the next.
  • Treatment and support are available at every stage; a stabilizing glove can help with the hand tremor specifically, while the broader condition is managed with medication and therapy.

After a Parkinson's diagnosis, one of the first questions is what lies ahead. Clinicians often describe the path using five stages, which give patients and caregivers a shared language for the changes that can occur. This guide walks through each stage — and, just as importantly, explains why the pace is so different from person to person, so the stages read as a map rather than a countdown.

What are the stages of Parkinson's Disease?

Parkinson's is a progressive condition of the nervous system that affects movement, with tremor, slowness, stiffness, and balance changes among its motor symptoms and others — such as loss of smell, pain, and sleep changes — on the non-motor side (NINDS, Parkinson's Disease). To track how it advances, clinicians use the Hoehn and Yahr scale, an international standard that rates PD across five stages (Hoehn & Yahr, Neurology, 1967). It's a framework for describing severity, not a schedule — and our comparison of the Hoehn and Yahr Scale and the UPDRS explains how clinicians measure progression in more detail.

The 5 stages of Parkinson's Disease

Stage 1

The earliest stage, with mild symptoms on one side of the body (unilateral involvement). Changes — slight differences in walking, posture, or facial expression — are often subtle enough that only close family notice them, and they usually don't interfere with daily activities. Diagnosis at this stage can be difficult without a clinical evaluation.

Stage 2

Symptoms appear on both sides of the body (bilateral involvement). Tremor and rigidity may become more noticeable, along with changes in facial expression, speech (softer or more monotone voice), and reduced blinking. Daily tasks take more effort, but the person generally remains independent. Stage 2 can develop months to years after stage 1.

Stage 3

The mid-stage, where loss of balance and slowed movement become clearly noticeable, and falls can occur because the body can't make rapid automatic adjustments. Everyday tasks take longer and may need some support, but the person can still perform them. Impairment is evident enough that diagnosis is usually straightforward by this point.

Stage 4

Symptoms are severe and limiting. The person can usually still stand without help, but movement is greatly impaired, and many need assistance with daily tasks. Walking aids such as a cane or walker are often used at this stage.

Stage 5

The most advanced stage, where many people need extensive help with daily activities and with rising or turning. Parkinson's may be accompanied by neuropsychiatric symptoms such as hallucinations or delusions in some individuals. Importantly, not everyone reaches stage 5 — progression varies widely, and some people stay at an earlier stage for a long time or never advance past it.

Steadying a Parkinson's hand tremor at any stage

Hand tremor is often one of the earliest Parkinson's symptoms and can persist as the condition moves up the scale, so a tool aimed squarely at it is useful at any point. The Steadi-3 Plus is an FDA-registered Class I medical device that counters hand tremor mechanically with a passive magnetic vibration absorber (tuned mass damping), with no electronics or batteries. Its effect was measured in a placebo-controlled study: compared with no device, 84% of wearers improved their tremor control, and compared with a placebo glove, 70% did (Steadiwear, Steadi-3 Plus validation study). It doesn't slow the disease or move anyone back down the Hoehn and Yahr scale — it steadies the hand for everyday tasks like eating, writing, and holding a cup, as one part of stage-by-stage care.

For the days a Parkinson's tremor makes the hands shake, a Parkinson's tremor glove can steady them — alongside medication, therapy, and exercise, not instead of them.

How fast does Parkinson's progress?

There's no single answer, because the rate differs so much between people — which is exactly why the Hoehn and Yahr scale describes stages but attaches no timeline (Parkinson's Foundation, Understanding Parkinson's). Some people progress slowly and spend years in an early stage; others move faster or develop more non-motor symptoms. Factors like age at onset, symptom pattern, and response to treatment all play a part, but none predicts any individual's course. In practice, averages are best treated as context for a conversation with your care team, not a personal forecast.

Treatment, support, and when to talk to your doctor

Treatment is available at every stage and aims to manage symptoms as the condition changes — medication, physiotherapy, speech and occupational therapy, exercise, and planning for safety and mobility. Early diagnosis helps guide timely decisions. Talk to your neurologist if symptoms change noticeably, if balance or swallowing becomes a concern, or if you simply want to understand what to expect — these conversations are where general staging becomes a plan that fits you.

Foire aux questions

They’re the Hoehn and Yahr stages: stage 1 (mild, one-sided symptoms), stage 2 (both sides, still independent), stage 3 (balance problems and falls, mid-stage), stage 4 (severe symptoms needing assistance), and stage 5 (advanced, needing extensive help). They describe severity, not a fixed timeline.

It varies widely. Some people stay in an early stage for many years; others progress faster. The Hoehn and Yahr scale intentionally has no set timeline, and no average predicts an individual’s pace — your neurologist is the best person to discuss your own outlook.

No. Many people never reach the most advanced stage. Progression differs from person to person, and some remain at an earlier stage long-term or have slower, milder symptoms throughout.

It’s an international standard scale, introduced in 1967, that rates Parkinson’s progression across five stages based on how far symptoms have spread and how much they affect balance and independence. Clinicians use it to describe and track the disease.

There’s no proven way to stop progression, but medication, regular exercise, and therapy help manage symptoms and maintain function and quality of life. Discuss the best approach for your stage with your care team rather than relying on general advice.

Références

  1. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427–442. PMID 6067254.
  2. Parkinson's Foundation. Understanding Parkinson's. Parkinson's Foundation: Understanding Parkinson's.
  3. NINDS. Parkinson's Disease. National Institute of Neurological Disorders and Stroke. NINDS: Parkinson's Disease.
  4. Steadiwear. Steadi-3 Plus validation study. Steadiwear: Steadi-3 Plus validation study.